Business Strategy for 2003
Focus on EMISPHERE® delivery agent performance, safety and scale up
Focus on formulation of carrier and drug
Eliminate late stage, expensive clinical development
Maintain tightly focused R&D effort
Cash Management Strategy
- Sufficient cash inflow from existing partners to ensure development of numerous potential blockbuster pharmaceutical product candidates
- Seek royalty driven deals with future partners
- Continue to build strong asset position for future licensing
- Not seeking outside capital; looking to maintain share base